Return to content in this issue

Long-term Remission of Wells Syndrome With Omalizumab

Coattrenec Y¹, Ibrahim Yasmine L², Harr T¹, Spoerl D^1*, Jandus P<sup>1*

1</sup>Division of Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty, Geneva, Switzerland
²Division of Clinical Pathology, University Hospital and Medical Faculty, Geneva, Switzerland
^*DS and PJ contributed equally to this work.

J Investig Allergol Clin Immunol 2020; Vol 30(1) : 58-59
doi: 10.18176/jiaci.0436